Publication:
Letter: proton pump inhibitor usage still seems to reduce the risk of high-grade dysplasia and/or oesophageal adenocarcinoma in Barrett's oesophagus

Simple item page
dc.contributor.authorsAydin, Y.; Akin, H.
dc.date.accessioned2022-03-14T04:29:50Z
dc.date.accessioned2026-01-11T08:42:57Z
dc.date.available2022-03-14T04:29:50Z
dc.date.issued2014
dc.identifier.doi10.1111/apt.12892
dc.identifier.issn1365-2036
dc.identifier.pubmedPMID: 25185738
dc.identifier.urihttps://hdl.handle.net/11424/238858
dc.language.isoeng
dc.relation.ispartofAlimentary Pharmacology & Therapeutics
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectFemale
dc.subjectHumans
dc.subjectMale
dc.subjectEsophagus
dc.subjectAdenocarcinoma
dc.subjectProton Pump Inhibitors
dc.subjectEsophageal Neoplasms
dc.subjectBarrett Esophagus
dc.titleLetter: proton pump inhibitor usage still seems to reduce the risk of high-grade dysplasia and/or oesophageal adenocarcinoma in Barrett's oesophagus
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage860
oaire.citation.startPage859
oaire.citation.titleAlimentary Pharmacology & Therapeutics
oaire.citation.volume7

Files

Collections

Araştırma Çıktıları